AstraZeneca a 'buy' for Deutsche Bank after lung cancer drug granted priority reviewProactive Investors • 04/20/22
AstraZeneca cancer drug receives priority FDA review as data points to its potential in lung cancerProactive Investors • 04/19/22
ENHERTU® Granted Priority Review in the U.S. for Patients with Previously Treated HER2 Mutant Metastatic Non-Small Cell Lung CancerBusiness Wire • 04/19/22
AmoyDx Enters into Master Collaboration Agreement with AstraZeneca for Multiple Companion Diagnostics Programs in China, EU and JapanGlobeNewsWire • 04/18/22
AstraZeneca topples Shell as London's top dog but what about the "march of the makers"?Proactive Investors • 04/07/22
AstraZeneca has cracked a whole new cancer treatment market, but how much is worth?Proactive Investors • 04/07/22
Harbour BioMed Announces Global Out-License Agreement with AstraZeneca for CLDN18.2xCD3 Bispecific Antibody HBM7022PRNewsWire • 04/07/22
AstraZeneca's Ultomiris Shows Sustained Improvements In Functional Activities In Neuromuscular DiseaseBenzinga • 04/06/22
PGA Champion Jason Day Launches Getting Out of the Rough Video Series With AstraZeneca to Support Lung Cancer Biomarker Testing AwarenessPRNewsWire • 04/04/22
AstraZeneca's Ondexxya wins approval for reversal of acute major bleeds in patientsProactive Investors • 03/29/22
Nuformix says patent application for reformulated AstraZeneca blockbuster has progressed to publication phaseProactive Investors • 03/28/22